Goel, S., Bulgaru, A., Hochster, H., Wadler, S., Zamboni, W., Egorin, M., ...
Background: The aim of this study was to determine the maximum tolerated dose, recommended phase II dose (RPTD) and toxicities of the FOG regimen (infusional 5-fluorouracil, oxaliplatin,...
Pivot, X., Wadler, S., Kelly, C., Ruxer, R., Tortochaux, J., Stern, J., ...
We report on two randomized trials performed in the USA and Europe, which compared methotrexate and nolatrexed as treatment for patients with recurrent head and neck cancer Eligibility criteria...
Biologic response modifiers in gynecologic malignancies.
Dutcher, J. P., Wadler, S., Wiernik, P. H.
Biological therapy is currently being investigated in the treatment of a number of malignancies. The hypothesis for the use of this therapeutic modality involves an attempt to stimulate an already...
Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study
Andreyev, H J N, Norman, A R, Cunningham, D, Oates, J, Dix, B R, Iacopetta, B J, ...
Researchers worldwide with information about the Kirsten ras (Ki-ras) tumour genotype and outcome of patients with colorectal cancer were invited to provide that data in a schematized format for...